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MutagenesisCalnexin is a type I endoplasmic reticulum lectin-like chaperone protein. In this study, we have used site-
speciﬁc mutagenesis to investigate the functional importance of glutamate E351 found at the tip of the P-
domain of calnexin, and tryptophanW428 found in the carbohydrate binding region of the globular domain of
the protein. The E351 and W428 calnexin mutants lost the ability to inhibit aggregation of IgY (glycosylated
substrate). The E351 mutation led to slightly enhanced ERp57 binding to calnexin, whereas W428 greatly
enhanced binding of ERp57 to calnexin. These ﬁndings indicate that modiﬁcation of a residue(s) in the
carbohydrate binding region may have a profound effect on the structural and functional properties of the P-
domain and consequently on association of calnexin with the folding enzyme ERp57.malate dehydrogenase; RU,
1 780 492 0886.
chalak).
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The endoplasmic reticulum (ER) plays important roles in protein
synthesis, folding, and post-translational modiﬁcation of membrane
associated, secreted, and integral membrane proteins and lipids [1,2],
withmany of the proteins being glycosylated. This task is performed in
the lumen of the ER, in conjunction with Ca2+-dependent chaperones
responsible for the appropriate folding of nascent glycoproteins and
the prevention of improperly folded proteins [3]. This folding program
is termed quality control and is comprised of several proteins
including calreticulin, calnexin and ERp57 [4,5]. Calnexin is a 90-kDa
membrane, lectin-like protein [6] that binds Ca2+ with high afﬁnity
[7,8], ATP [6,9,10] and non-glycosylated proteins [7,11], in conjunction
with calreticulin and ERp57. Calnexin contains several structural and
functional domains. One of themost important domains of the protein,
involved in the chaperone function of calnexin, resides in the lumen
of the ER and forms a chaperone module [12]. This region of calnexin
has been referred to as “soluble calnexin” and is composed of the N-
terminal globular domain and central P-domain [13]. The P-domain of
calnexin forms an extended arm region that contains the conserved
proline residues, the four tandem repeats, and binds the oxidoreduc-
tase ERp57 [13–15].
Site-speciﬁc mutational analysis of calreticulin identiﬁes several key
amino acid residues involved in the chaperone function of the protein
and complex formation with the oxidoreductase ERp57 [16,17]. Amino
acid residues H153, W244 and W302 located in the N-terminal globulardomain of calreticulin are essential for its chaperone function [16,17],
while E239, D241, E243 and W244 amino acid residues located in the P-
domain are identiﬁed as critical for ERp57 binding to the P-domain of
calreticulin [17]. Interestingly, mutation of W302 located in the globular
N-terminal domain of calreticulin results in greatly increased binding of
ERp57 to calreticulin [17], suggesting that changes in the globular
domain of the chaperone calreticulinmay affect its ability to recruit and
form stable complexes with folding enzymes. A number of amino acid
residues are highly conserved between calreticulin and calnexin [12].
This includes W428 in the globular N-domain of calnexin (W302 in
calreticulin) which may be involved in the interaction with substrate
and E351 (E243 in calreticulin) located at the tip of the P-domain which
may be responsible for binding ERp57. Similar site-speciﬁcmutagenesis
studies of calnexin, an integral membrane lectin-like chaperone have
not been previously carried out.
Here we focused our studies on a glutamate, E351, found at the tip
of the P-domain of calnexin, potentially interacting with ERp57, and a
tryptophan, W428, found in the carbohydrate binding region of the
globular domain of calnexin, possibly in contact with substrate. As
expected, wild type soluble calnexin efﬁciently affected aggregation of
IgY (glycosylated substrate), but the E351 and W428 mutants lost the
ability to prevent the aggregation of IgY. Similar to calreticulin,
mutation of W428 signiﬁcantly enhanced binding of calnexin to ERp57
while the E351 mutation only slightly increased binding to ERp57.
2. Experimental procedures
2.1. Materials
Trypsin, ATP-Mg2+, CaCl2, ZnCl2, and EGTAwere fromSigma. Sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
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IgY puriﬁcation system was from Promega. Ni-NTA agarose beads were
from Qiagen. CM5 sensor chips, Amine Coupling Kit and the BIA eval-
uation analysis program were from BIAcore Inc. All chemicals were of
the highest grade available.
2.2. Cloning, expression and puriﬁcation of recombinant proteins
For Escherichia coli expression of wild-type soluble mouse calnexin
(N+P-domain, not containing the transmembrane and C-terminal
domain), cDNAwas ampliﬁed and cloned into NcoI and XbaI restriction
enzyme sites of plasmid pBAD/glIII A (Invitrogen) to generate pBAD-
HisCNX. Site speciﬁc mutagenesis was carried out using a megaprimer
polymerase chain reaction technique using the Gene Amp PCR system
9700 thermal cycler and Pfx DNA polymerase [16]. The following
mutants were generated: E351R and W428A.
Proteinswere expressed in Top10F E. coli. Over 90%of theHis-tagged
protein was puriﬁed to homogeneity by one-step Ni2+-nitrilotriacetic
acid-agarose column chromatography [16,17]. Protein concentration
was determined by a Beckman System 6300 amino acid analyzer or by
using Bio-Rad protein assay reagent using bovine serum albumin as a
standard [16,17]. ERp57 was expressed in E. coli and puriﬁed as pre-
viously described [18].
2.3. Aggregation assays
The protein aggregation assay was carried out in a mixture con-
taining soluble wild-type or mutant calnexin [16,17,19]. IgY was
isolated from chicken egg yolk according to the protocol of the
EGGstract IgY puriﬁcation system and denature for aggregation assay.
The aggregation assay using IgY (0.25 µM) was performed in buffer
containing 10 mM Tris pH 7.4, 150 NaCl, and 5 mM CaCl2 [16,17],
followed by the addition of wild-type or mutant soluble calnexin
(0.125 µM). Samples were incubated at 42 °C, with light scattering
measured using a spectroﬂuorometer system C43/2000 (PTI) equipped
with a temperature controlled cell holder; the excitation and emission
wavelengths were set to 320 and 360 nm, respectively, with experi-
ments carried out between three and six repetitions [16,17].
2.4. Intrinsic ﬂuorescence, proteolytic digestions and circular dichroism
(CD) analysis
Intrinsic ﬂuorescence measurements were performed at 25 °C in
a spectroﬂuorometer system C43/2000 (PTI) as described [16,17].
Wild-type and mutant soluble calnexin (3 µM) were used for ﬂuores-
cence measurement in a buffer containing 10 mM 3-(N-morpholino)
propanesulfonic acid, pH 7.1, 3 mM MgCl2, and 150 mM KCl. The
excitation wavelength was set to 286 nm, and the range of emission
wavelength was set to 295–450 nm. The effect of 1 mM Zn2+, 2 mM
Ca2+ and 1 mMATP-Mg2+ on the intrinsic ﬂuorescence of the protein
was evaluated at a wavelength of 334 nm, with experiments per-
formed a minimum of three times.
Ten microgram of puriﬁed wild-type or mutant soluble calnexin
was incubated at 37 °C with trypsin at 1:100 (trypsin/protein; w/w);
ﬁnal trypsin concentration 10 µg/ml [20] in the absence or presence of
2 mM Ca2+, 1 mM Zn2+ or 1 mM ATP-Mg2+. Time course carried out
with samples taken at times indicated in ﬁgure legend. The proteins
were separated by SDS-PAGE (10% acrylamide) and stained with
Coomassie Blue, with experiments carried out a minimum of three
times [16].
CD analysis was performed at 25 °C using a Jasco J720 spectro-
polarimeter (Jasco Inc., Easton, MD) in the absence or presence of
2 mM Ca2+, 1 mM Zn2+ or 1 mM ATP-Mg2+ [20], with between 8 and
16 scans done per sample. Three hundred µg of protein per ml of
buffer (10 mM Tris, pH 7, 1 mM EDTA) was analyzed.2.5. Surface plasmon resonance (SPR) analysis
The BIAcore sensor chips were activated, coupled and blocked
using the Amine Coupling Kit from BIAcore as previously described
[17]. Brieﬂy, two lanes on a CM5 chip were activated using a 1:1
mixture of N-hydroxysuccinimide/N-ethyl-N′-(3-dimethylaminopro-
pyl)-carbodiimide hydrochloride. One uM of puriﬁed protein, termed
ligand (soluble calnexin or calnexin mutants), was immobilized on
the second lane in 10 mM sodium acetate buffer at pH 4 until the lane
was coupled, approximately 2000 Resonance Units (RU). The control
lane and remaining sites in the coupled lane were then blocked with
1 M ethanolamine at pH 8.5. The experiments were performed
between six and eight times at 20 °C using running buffer containing
20 mM Tris, pH 7, 135 mM KCl, 2 mM CaCl2, 0.05% Tween-20, 100 µM
phenylmethanesulphonylﬂuoride, 200 µM benzamidine, 0.05 µg/ml
aprotinin, 0.025 µg/ml phosphoramidone, 0.05 µg/ml N-α-tosyl-L-
lysinyl-chloromethylketone, 0.1 µg/ml N-tosyl-L-phenylalanine chlor-
omethyl ketone, 0.05 µg/ml 4-(2-aminoethyl)-benzenesulfonylﬂuor-
ide, 0.05 µg/ml E-64, 0.025 µg/ml leupeptin, and 0.01 µg/ml pepstatin
[21] at a ﬂow rate of 30 µl/min to minimize mass transfer effects.
ERp57 was used as the analyte in a titration curve of 5000 to 5 nM,
with buffer used as 0 nm (representative curves are shown at a
concentration of 5000 nM). The maximum relative response value for
each injection was calculated using the kinetic assay result wizard
(BIAcore control software 3.2). Kinetic analysis performed using
BiaEvaluation Software (BIAcore) generating ka, a measure of
association; kd, a measure of dissociation; and KD, a measure of
afﬁnity. All curves were ﬁtted using the Drifting Baseline Model (1:1
Langmuir binding).
3. Results
3.1. Soluble calnexin mutants had a signiﬁcantly decreased ability to
prevent aggregation of IgY
In order to examine the role of E351 and W428 in soluble calnexin
chaperone activity, we employed an in vitro assay used previously by
Williams' group [19]. This assay utilizes IgY, a glycosylated substrate
[19]. IgY is susceptible to heat-induced aggregation and has been used
as a model substrate in aggregation and refolding assays with other
molecular chaperones [22–24]. Fig. 1A shows that one-step puriﬁca-
tion of the recombinant proteins on a Ni-column was sufﬁcient. Solu-
ble calnexin and mutant proteins were incubated with IgY followed
by measurement of light scattering. As expected, wild-type soluble
calnexin completely prevented the aggregation of IgY (Fig. 1B). Fig. 1B
shows that E351R and W428A mutants were only partially able to pre-
vent the aggregation of IgY, in contrast to wild type soluble calnexin.
This indicated that these mutations must signiﬁcantly change the
conformation of calnexin, decreasing the ability of calnexin to chap-
erone the glycosylated substrate, IgY.
3.2. CD analysis indicated the addition of Zn2+ resulted in changes in the
conformation of calnexin
We have shown previously that mutation of speciﬁc residues in
calreticulin causes signiﬁcant conformational changes in the protein
[16,17]. To determine whether calnexin mutations resulted in
conformational changes in the protein, we carried out CD analysis of
the puriﬁed soluble proteins. Fig. 2 shows that the CD spectra for
soluble calnexin and the E351R and W428A mutants were marginally
divergent in shape. Further analysis of wild type soluble calnexin as
demonstrated in Table 1 indicated that there were slight changes in
α-helix and β-sheet secondary structures with the addition of Ca2+,
Zn2+ and ATP-Mg2+. Addition of Ca2+ resulted in a 4% (SD=1.3%)
loss in the percentage of β-turn and a corresponding increase in the
random coil structure of soluble calnexin, but with little change in α-
Fig. 1. Effects of soluble wild-type, E351R and W428A calnexin on thermal aggregation of IgY. A. Sodium dodecyl sulfate gel electrophoresis of E. coli expressed and puriﬁed soluble
wild-type, E351R and W428A calnexin. Coomassie blue stained gel; Lane 1 is prestained marker, lane 2 is 10 µg of soluble wild type calnexin, lane 3 is 10 µg of E351R calnexin mutant,
lane 4 is 10 µg of W428A calnexin mutant. Minor bands are degradation products. B. Wild-type, E351R andW428A calnexin were incubated with IgY at 42 °C followed bymonitoring of
aggregation at 360 nm. Experiments performed between three and six repetitions. Blue indicates IgY alone, black indicates wild type soluble calnexin, red indicates E351R mutant
calnexin, and green indicates W428A mutant calnexin.
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(SD=1%) in the α-helix secondary structure. The addition of ATP-
Mg2+ resulted in only 2% and 3% increase in α-helix and β-sheet
structure, respectively with less random coil.
3.3. Trypsin digestion of soluble calnexin and calnexin mutants indicated
W428A had increased accessibility to trypsin
Previous experiments using calreticulinmutants identiﬁed speciﬁc
amino acid residues that are responsible for modifying the trypsin
accessible portions of the protein [17]. We used the same technique to
determine the effect of site speciﬁc mutations on calnexin and the
accessibility of trypsin to the protein. Soluble calnexin and mutant
proteins were incubated with trypsin as described in Section 2, and
SDS-PAGE was performed to observe the digestion pattern of the
proteins in the absence or presence of Ca2+, Zn2+ or ATP-Mg2+
(Fig. 3). Wild-type soluble calnexin was partially resistant to trypsin
as observed by a portion of the full length protein being present at the
20-min time point. This protection was further enhanced in the
presence of Ca2+, but the protection was completely lost with Zn2+ or
ATP-Mg2+. These results imply that both Zn2+ and ATP-Mg2+ binding
resulted in wild-type soluble calnexin becoming more accessible toFig. 2. Circular dichroism (CD) analysis of soluble puriﬁed wild-type, E352R and W428A
calnexin. Data generated from between 8 and 16 runs per sample and plotted as molar
ellipticity versus wavelength (nm). Blue indicates water, black indicates wild type
soluble calnexin, red indicates E351R mutant calnexin and green indicates W428A
mutant calnexin. No signiﬁcant difference observed between wild type soluble calnexin
and the two calnexin mutant proteins, E351R and W428A.trypsin digestion, while addition of Ca2+ resulted in trypsin having
less accessibility to the protein. Interestingly, one of the two site
speciﬁc mutations, the W428A mutation, resulted in very little pro-
tection of the protein from trypsin as compared to wild type protein.
Only in the presence of Ca2+ was this protection recovered. This
implied that the tryptophan mutation resulted in conformational
changes that expose more trypsin accessible sites, but that addition of
Ca2+ once again resulted in the recovery of protein protection (Fig. 3).
Potentially, Ca2+ binding to the protein may overcome the loss in
structure that resulted from mutation of the tryptophan residue. The
other mutation, E351R, did not result in any signiﬁcant changes in
trypsin accessibility as compared to wild-type protein.
3.4. Addition of Ca2+ and ATP-Mg2+ resulted in decreased
intrinsic ﬂuorescence
Each protein has an internal intrinsic ﬂuorescence emission pro-
vided by tryptophan residues that is affected by the movement within
the protein of charged groups as well as by global changes in hy-
drophobicity. This intrinsic ﬂuorescence provides critical information
on changes in tertiary structure and can be used in conjunction with
trypsin digestion to identify structural modiﬁcations. Fluorescence
emission spectra were measured for soluble wild-type calnexin and
for calnexinmutants at varying concentrations of Ca2+, Zn2+ and ATP-
Mg2+. Fig. 4A demonstrates that soluble calnexin had an emission
maximum at 334 nm. There was a progressive decrease in the in-
tensity of ﬂuorescence in the presence of increasing concentrations of
Ca2+ (Fig. 4B), indicative of Ca2+-dependent conformational changes
in the protein. Similar changes in intrinsic ﬂuorescence were observed
for ATP-Mg2+ (Fig. 4D). Interestingly, addition of Zn2+ did not affect
the ﬂuorescence emission spectra for soluble calnexin or for the
mutants (Fig. 4C). Fluorescence emission spectra for the calnexinTable 1
CD analysis of soluble calnexin with the addition of Ca2+, Zn2+ and ATP-Mg2+. CD
analysis was performed on puriﬁed soluble calnexin in the presence or absence of Ca2+,
Zn2+ or ATP-Mg2+ as described under Section 2. The addition of Ca2+, Zn2+ and ATP-
Mg2+ resulted in little to no change. Mean±SD of the compiled results.
α-Helix β-Sheet β-Turn Random Scale
Calnexin .20±0.008 .22±0.009 .19±0.010 .39±0.013 1.001
+2 mM Ca2+ .19±0.010 .22±0.011 .15±0.013 .43±0.018 1.000
+1 mM Zn2+ .16±0.010 .19±0.010 .21±0.013 .43±0.015 1.000
+1 mM ATP .22±0.007 .25±0.009 .17±0.010 .36±0.013 1.001
Fig. 3. Trypsin digestion patterns of puriﬁed soluble wild-type, E352R and W428A calnexin in the absence and presence of Ca2+, Zn2+ or ATP. Puriﬁed soluble calnexin and mutant
proteins, E351 or W428 were incubated with trypsin at 1:100 (trypsin/protein; w/w) at 37 °C. Aliquots were taken at the time points indicated, and the proteins were separated by
SDS-PAGE and stained with Coomassie Blue as described under Section 2. Trypsin digests were also performed with the addition of 2 mM Ca2+, 1 mM Zn2+ or 1 mM ATP-Mg2+.
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observed for the wild-type protein, indicating that mutation of these
residues in soluble calnexin did not signiﬁcantly affect the conforma-
tion of the protein.
3.5. Surface Plasmon Resonance (SPR) analysis demonstrated W428A
mutation resulted in enhanced binding of ERp57
Recently, a new technique termed SPR has been used to identify
biomolecular interactions between proteins [17,25]. This method
utilizes the measurement of mass change to identify binding between
two molecules. A mass increase occurs when molecules in the test
solution bind to a target molecule and when they dissociate, mass
decreases. These changes can be monitored in real time using acontinuous sensorgram, with quantitative information on speciﬁcity
of binding, kinetics and afﬁnity identiﬁed.
Puriﬁed soluble calnexin or mutant proteins were covalently
linked to the chip as the ligand, with ERp57 in solution as the analyte.
An increase in mass was observed between wild-type soluble protein
and ERp57, indicating an interaction between the two proteins
(Fig. 5). This mass transfer was ampliﬁed slightly upon mutation of
E351R but signiﬁcantly increased (3-fold) with the mutation of W428A.
This indicated that the E351R mutation did not signiﬁcantly affect the
interaction with ERp57, but that the W428A mutant enhanced binding
of ERp57. The conserved glutamate residue in calreticulin (E243)
slightly reduced the interaction with ERp57 [17], but similar to the
W302A mutant of calreticulin [17], the W428A mutation actually
enhanced the interaction of ERp57 with calnexin. This indicated to us
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Fig. 4. Intrinsic ﬂuorescence of puriﬁed soluble wild-type calnexin, E352R andW428A calnexin. Intrinsic ﬂuorescence emission spectra analyses of calnexin and calnexin mutants, E351
orW428, were carried out as described under Section 2 and performed a minimum of three times. Absorbance was monitored at 334 nm in the presence and absence of molecules. A.
Emission scan performed on soluble wild type calnexin and calnexin mutant proteins, E351R andW428A demonstrating an absorbance maximum at 334 nm. Black line indicates wild
type soluble calnexin, red line indicates E351R mutant calnexin and green line indicates W428A mutant calnexin. B, C, D. Ca2+, Zn2+ or ATP-Mg2+ were added at the concentrations
indicated.
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domain could affect interaction of the P-domain with ERp57,
presumably because of a shifting in the tertiary structure of the
globular domain. Mutation of W428 may also result in conformational
changes which expose another ERp57 binding site, or strengthen the
primary site observed. Kinetic analysis (Table 2) of the interaction
of ERp57 with soluble wild type and mutant proteins did not dem-
onstrate any signiﬁcant differences in association rate, termed ka; the
afﬁnity, KD; or the dissociation rate, Kd; as compared to wild typeFig. 5. ERp57 interaction with puriﬁed soluble E352R and W428A calnexin mutants,
characterized by Surface Plasmon Resonance (SPR). Puriﬁed soluble calnexin or E351
andW428 proteins were covalently coupled to a CM5 chip as described under Section 2.
Running buffer containing a titration of ERp57 was washed over the coupled proteins
and mass changes were recorded with a real time sensorgram, complete with kinetic
analysis. Sensorgrams were carried out a minimum of three times with a representative
graph shown.protein. Interestingly, although calnexin forms functional complexes
with ERp57 via its P-domain [14,26,27], the W428 calnexin mutant
exhibited greatly increased binding of ERp57. This indicated that a
single amino acid mutation in the globular N-domain of calnexin
affects the structure and function of the distant P-domain.
4. Discussion
In this study, we performed functional analysis of speciﬁc amino
acid residues in calnexin, a lectin-like chaperone localized to the ER,
determining the effect of mutations in calnexin on folding of the
glycosylated substrate IgY [17,28]. This is an excellent model to in-
vestigate the function of calnexin and to monitor the effect of speciﬁc
amino acid mutations. Previously, we have used this approach to
identify amino acid residues involved in the chaperone function ofTable 2
Kinetic analysis of soluble wild type and mutant calnexin interaction with ERp57 as
demonstrated using SPR. SPR kinetic analysis was performed on soluble wild type and
calnexin mutant proteins, E351 or W428 in the presence of puriﬁed ERp57. A dilution of
ERp57 from 5000 to 5 nM was passed over immobilized ligand (calnexin or calnexin
mutants) with the resultant analysis of association, dissociation and afﬁnity calculated.
No signiﬁcant differences were observed. Data from three separate experiments.
Kinetics Calnexin Calnexin E351R Calnexin W428A
Ka (association) 4.89E+03 3.15E+03 5.33E+03
Kd (dissociation) 2.01E−03 1.82E−03 2.39E−03
KD (afﬁnity) 4.19E−07 5.70E−07 4.81E−07
1440 J. Groenendyk et al. / Biochimica et Biophysica Acta 1808 (2011) 1435–1440calreticulin [16,17]. In the present study, we focused on a glutamate
E351 found at the tip of the P-domain, a residue we believed to be
potentially involved in the interaction with ERp57, and a tryptophan
W428 located in the carbohydrate binding region of the globular do-
main and possibly in contact with glycosylated substrate. We showed
that soluble wild type calnexin completely prevented the aggregation
of IgY, while addition of either mutation, E351 or W428, failed to
prevent the aggregation of IgY. This indicated that the E351 and W428
mutations affected calnexin chaperone function towards this glyco-
sylated substrate in vitro. These ﬁndings suggested that the E351R and
the W428A mutations resulted in disruption of the chaperone activity
of the protein, presumably as a result of conformational changes,
which also may affect Ca2+, Zn2+, or ATP-Mg2+ binding to the
protein. Calnexin interaction with Zn2+ [14], Ca2+ and ATP-Mg2+ [9]
may affect protein structure and consequently its function. CD
analysis of soluble wild type calnexin indicated that Zn2+, Ca2+
and ATP-Mg2+ addition resulted in a negligible change in secondary
structure. CD analysis revealed no signiﬁcant change in the CD spec-
trum of the E351R and W428A mutants. However, increased accessi-
bility of the W428 (but not E351) mutant to limited trypsin digestion
indicated conformational changes in the W428 calnexin mutant that
likely contributed to its chaperone function.
Calnexin binds its glycoprotein substrates primarily via mono-
glucosylated glycans (Glucose1Mannose7–9 N-acetylglucosamine2).
The 3D structure of the luminal domain of calnexin shows a binding
site for the terminal glucose moiety of the carbohydrate within the
globular N-domain of the protein [13]. The glucose binding pocket
contains a centrally located tryptophan residue W428 and several
charged amino acid residues [13]. Here we showed that the centrally
located W428 residue in calnexin was important and necessary for
the chaperone function of the protein in vitro, likely because of a
critical role in carbohydrate binding. Mutation of W428 may produce
important structural changes in the sugar binding site and/or in the N-
terminal domain, which led to the loss of calnexin chaperone function.
This was supported by our observation that the W428 mutant failed to
efﬁciently prevent thermal aggregation of IgY, and had increased
accessibility to trypsin. Also, the residue W428 may form a hydrogen
bond with the Mannose3 of the sugar moiety [29]. Calnexin forms
functional complexes with ERp57 via its P-domain [15]. Interestingly,
mutation ofW428 in the substrate binding globular domain of calnexin
resulted in greatly increased binding of ERp57. We observed similar
behavior for a corresponding mutation (W302) in calreticulin, leading
to signiﬁcantly increased binding of ERp57 [17]. These ﬁndings indi-
cated that calnexin and calreticulin must share similar molecular fea-
tures involved in substrate binding and association with the folding
enzyme, ERp57. Likely, modiﬁcation of a residue(s) in the carbohy-
drate binding region has a profound effect on the structural and func-
tional properties of the P-domain, as documented by increased ERp57
binding by calnexin mutant W428 (and the calreticulin mutant W302
[17]).
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